Michael E Wright

Title: Michael E Wright: Innovator in Prostate Health Diagnostics

Introduction

Michael E Wright is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medical diagnostics, particularly concerning prostate health. His innovative work has led to the development of a patented method that aids in diagnosing prostate neoplastic conditions.

Latest Patents

Wright holds a patent for "Methods to determine androgen responses in prostate cells." This invention provides a method for diagnosing or predicting susceptibility to a prostate neoplastic condition in an individual. The method involves determining a level of RDC1 in a sample from the individual and comparing this level to a reference level of RDC1. A level of RDC1 in the sample that is two-fold or more higher than the reference level indicates the presence of, or susceptibility to, a prostate neoplastic condition in the individual. This patent is a significant advancement in the field of prostate health diagnostics.

Career Highlights

Michael E Wright is affiliated with the Institute for Systems Biology, where he applies his expertise in systems biology to further research in health diagnostics. His work at this institute has allowed him to collaborate with other leading scientists and contribute to groundbreaking research.

Collaborations

Wright has worked alongside Rudolf Hans Aebersold, a prominent figure in the field of proteomics. Their collaboration has likely enhanced the research output and innovation at the Institute for Systems Biology.

Conclusion

Michael E Wright's contributions to prostate health diagnostics through his patented methods exemplify the impact of innovative thinking in medical research. His work continues to pave the way for advancements in diagnosing prostate neoplastic conditions, ultimately benefiting patient care.